| |
|
|
umbAdvance.
Advance your company amidst the BioPark's thriving community of translational research centers, CROs, venture-backed start-ups and clinical treatment facilities.
David Block,
CEO, Gliknik Inc.
umbDiscover.
Discover the collaborative research opportunities and translational science taking place at the University of Maryland, Baltimore.
The University of Maryland, BioPark.
umbInvent.
Invent the next generation of bioscience innovations and services in the BioPark's advanced, flexible wet lab and office environment.
Paragon Bioservices
umbAdvance.
Advance your company amidst the BioPark's thriving community of translational research centers, CROs, venture-backed start-ups and clinical treatment facilities.
Faculty Researchers, University of Maryland Center for Vascular and Inflammatory Diseases.
umbDiscover.
Discover the collaborative research opportunities and translational science taking place at the University of Maryland, Baltimore.
Biotechnology Student, Life Science Institute, Baltimore City Community College
umbInvent.
Invent the next generation of bioscience innovations and services in the BioPark's advanced, flexible wet lab and office environment.
Jacques Ravel, a leading microbial genomics scientist at the Institute for Genome Sciences, reveals the secrets of microbes.
umbAdvance.
Advance your company amidst the BioPark's thriving community of translational research centers, CROs, venture-backed start-ups and clinical treatment facilities.
Paragon Bioservices
umbDiscover.
Discover the collaborative research opportunities and translational science taking place at the University of Maryland, Baltimore.
Dr. Eddy Agbo with Anne Derrick in Fyodor Biotechnologies lab.
umbInvent.
Invent the next generation of bioscience innovations and services in the BioPark's advanced, flexible wet lab and office environment.
PathSensors CEO Ted Olsen in his lab at the BioPark.
umbAdvance.
Advance your company amidst the BioPark's thriving community of translational research centers, CROs, venture-backed start-ups and clinical treatment facilities.
Maryland Proton Treatment Center
umbDiscover.
Ablitech Team-(pictured L to R) Chief Science Officer Dr. Nick Hammond, CEO Dr. Ken Malone, Research Scientist Dr. Srinivas Rapireddy-moves in new lab at UM BioPark's BioInnovation Center (February 2012).
|
|
|
| | | |
Featured BioPark Tenant
|
SNBL Clinical Pharmacology Ce
|
SNBL Clinical Pharmacology Center, Inc. is a 96-bed, state-of-the-art, Phase I/IIa Clinical Pharmacology Center. SNBL partners with pharmaceutical companies to accelerate product development through early stage clinical trials and supports complex, multi-faceted Phase I Programs designed to understand the science behind human safety and tolerability. SNBL’s parent company, Shin Nippon Biomed...
more
www.snbl-cpc.com
410-706-8877
|
|
|
|
|
|
|
Featured BioPark Building
MD Proton Treatment Center
|
|
The Maryland Proton Treatment Center ("MPTC") will be a state of the art, leading edge cancer center that will bring a highly advanced form of cancer treatment available today - proton therapy -to Baltimore, the State of Maryland, Washington, DC, Delaware and Northern Virginia. This center will feature five treatment rooms housed in an 110,000 square-foot facility in the University of Maryland BioPark on the University of Maryland, Baltimore campus. This cutting edge outpatient facility will also feature ground floor retail and includes space for research and training. The Maryland Proton Treatment Center is expected to begin treating patients in 2015.
View More Info »
|
|
|
|
|
|
Upcoming Events
|
|
|
|
| |
|
|
BioPark
University of Maryland Baltimore
801 West Baltimore Street
Baltimore, MD 21201
|
|
|
| |
|
Copyright 2009. BioPark at the University of Maryland Baltimore
|
|
|
|
